AI in Pharma & Healthcare: Hype or Reality?
Artificial Intelligence was long hailed as the revolutionary force that would transform the pharmaceutical and healthcare industries. But now that the initial excitement has settled, what’s left of the big promises? Which AI applications have actually made a difference, where are the biggest hurdles, and what comes next?
Find the answers in our latest whitepaper: “Current Implementation of AI Applications in the Pharmaceutical and Healthcare Industry.”
This whitepaper, created with STORM by Stanford University and edited by Dr Henriette Wolf-Klein, offers a clear and concise overview of real-world AI applications – from accelerating drug discovery and optimizing clinical trials to improving diagnostics and enabling personalized medicine.
Discover which technologies have proven themselves in practice, where the industry still faces challenges, and how ethical and regulatory questions are shaping AI adoption today. Real-life case studies and emerging trends help you separate lasting innovation from fleeting hype.
Download your copy now: “Current Implementation of AI Applications in the Pharmaceutical and Healthcare Industry.”
We hope you find the content insightful and engaging.
With this qualification course, you can continue your education in a structured manner in all CMC topics, with a technical focus on development methods, manufacturing processes, CMC documents, change management, and much more.
Attend one of our free pre-meetings to familiarise yourself with the Learning Space and the various ways in which you can interact during the event
Global variations and lifecycle management - covering key regions: USA, Asia (China, Japan, South Korea), LATAM (Central America, Brazil), and Gulf Cooperation Council (GCC). Take this opportunity to discuss your specific daily business challenges with our experts and network with peers to see how others approach similar issues!
Participants in this qualification course will receive thorough training on the main regulatory duties, from marketing authorisation applications to lifecycle management. This is the ideal preparation for starting a career in drug regulatory affairs. After course completion a certificate will be awarded.
Do you want to strategically plan your early phase clinical trials (phase I/IIa) from the start to accelerate drug development? Then gain tips and hands-on experience in this online seminar!
The conference will cover recent updates and practical implications of the EU pharmaceutical legislation, management of supply shortages, and the new EU Variation regulation. Additionally, it will address the latest developments in quality guidelines, impurities (with a focus on nitrosamines), and the application of AI in CMC and quality processes.
Project management in GxP - Managing projects successfully and efficiently in a regulated environment!
This seminar provides an in-depth exploration of EU drug marketing authorisation, focusing on regulatory frameworks, application types and procedures. It covers mutual recognition, decentralised and centralised procedures (MRP, DCP, CP) in detail, providing essential insights for successful EU drug approval.
Attend this seminar to gain in-depth knowledge of the CCDS concept, global labelling requirements, and practical insights into market-specific regulations in the EU and USA.
Are you new to pharmacovigilance and looking to kick-start your career? Then this online course is just for you. Gain a comprehensive overview of pharmacovigilance, regulatory requirements in the EU and implementation in only two days. Book now!
Global regulatory requirements for drug device combination products (DDCs): You will receive a regulatory overview for the EU, the US, China, MENA, Mexico and other LATAM countries, plus you will obtain tips and tricks by (local) experts on how to speed up the approval process.
